Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era.
about
Left atrial enlargement and NT-proBNP as predictors of sudden cardiac death in patients with heart failure.Plasma biomarkers for prediction of sudden cardiac death: another piece of the risk stratification puzzle?Two problems with analyzing natriuretic Peptide levels: obesity and acute myocardial infarctionHigh N-terminal pro-B-type natriuretic peptide levels are associated with reduced heart rate variability in acute myocardial infarction.Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failureEarly discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk Score.Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapiesBiomarkers in electrophysiology: role in arrhythmias and resynchronization therapy.Epidemiology and genetics of sudden cardiac deathDrug and drug-device therapy in heart failure patients in the post-COMET and SCD-HeFT era.Human recombinant-B-type natriuretic peptide protect ventricular function and structure in ST-elevation myocardial infarction.Impact of implantable-cardioverter-defibrillator trials on clinical management of patients with heart failure.N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarction.The optimal time of B-type natriuretic peptide sampling associated with post-myocardial infarction remodelling after primary percutaneous coronary intervention.Sudden cardiac death: prevalence, pathogenesis, and prevention.Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein as predictors of sudden cardiac death among women.Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis.Biomarkers in atrial fibrillation, ventricular arrhythmias, and sudden cardiac death.Review on natriuretic peptides: where we are, where we are going.Prognostic role of high-sensitivity C-reactive protein and B-type natriuretic peptide in implantable cardioverter-defibrillator patients.The prediction of ICD therapy in multicenter automatic defibrillator implantation trial (MADIT) II like patients: a retrospective analysis.Mechanism of sudden cardiac death in pigs with viable chronically dysfunctional myocardium and ischemic cardiomyopathy.Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.Insights into the change in brain natriuretic peptide after ST-elevation myocardial infarction (STEMI): why should it be better than baseline?A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction.B-type natriuretic peptide levels predict event-free survival in patients with implantable cardioverter defibrillators.N-Terminal Pro-Brain Natriuretic Peptide Level is Associated With Severity and Complexity of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome.Osteopontin and galectin-3 predict the risk of ventricular tachycardia and fibrillation in heart failure patients with implantable defibrillators.Biomarkers as predictors of sudden cardiac death in coronary artery disease patients with preserved left ventricular function (ARTEMIS study)
P2860
Q30542622-E6CF4240-F219-47B3-A372-F6ABABD8DDDDQ33353044-92B09844-505A-402A-99D7-CDD2CBC4960FQ34434678-7C65E4F4-5D97-48EA-ACFB-BA485DD002F5Q34446778-C68E0946-0277-44EA-9FAF-9D2C513EFEFBQ34472413-2C96D540-5F81-46E8-98C1-630ACE3181B8Q35114904-2AD32C3F-8F4A-408D-9FD4-9366D2424769Q35771323-95B4DA50-DFCB-4282-B93F-B66BB648C90DQ35805412-16953496-803C-4F67-A595-9604F5823591Q36102464-C1B21877-DA72-4AC9-91D8-27A87E3CEA8EQ36167689-1BDF583B-5FBB-4515-9A63-BF065396DF22Q36261974-75D6EE70-D445-4DAC-86A6-298D6B76123DQ36381963-310E6888-DB95-4E0E-8147-C47D14168934Q36921083-89037773-8211-4000-8FAF-0126A43EE81DQ37107870-B901E31E-4CA4-48AA-BAB3-846392A91D38Q37165374-E4C24508-4495-4B40-9D8D-2CB47E87BFD7Q37193184-E68D75DB-DC0F-4458-B6B1-5615F366ADD0Q37374009-4AA40044-756E-4843-AF20-27ABCA426950Q37605486-2E6B851D-4C99-4AB3-85B6-542AEB368AA8Q37808764-4F9709FE-8D03-46EE-A87F-C060B99F6501Q38089931-CF2E22DB-6A09-4BA1-866C-81D97712B2CCQ39677893-EA798C1E-2528-4E9C-A1EF-433EAE256D85Q43009874-601667F1-662C-406A-9FB8-A4AE43C4E670Q46639330-EF2C68C9-4442-4581-A7D2-3D7B1FE653A4Q48170655-80B21696-A3FC-4235-AFFB-F6855156BAA7Q48175323-34FBFEE2-28AB-4BEA-A01E-40117BA29C55Q48194474-4A5C85B9-CA7A-405B-9D54-E034AC3264C8Q48402146-188ADC9E-2194-4D05-BCD9-2EEE399E7DFDQ48681415-0C28B75B-677A-4E63-B237-049139262E7CQ48898746-6DD25965-0DE3-409E-BA8B-A69B203DADD7Q58727369-AC355508-545C-4327-9EBC-90CDE6D24C2A
P2860
Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Natriuretic peptides as predic ...... tion in the beta-blocking era.
@en
Natriuretic peptides as predic ...... tion in the beta-blocking era.
@nl
type
label
Natriuretic peptides as predic ...... tion in the beta-blocking era.
@en
Natriuretic peptides as predic ...... tion in the beta-blocking era.
@nl
prefLabel
Natriuretic peptides as predic ...... tion in the beta-blocking era.
@en
Natriuretic peptides as predic ...... tion in the beta-blocking era.
@nl
P2093
P1476
Natriuretic peptides as predic ...... tion in the beta-blocking era.
@en
P2093
Heikki V Huikuri
Jari M Tapanainen
Juhani Leppäluoto
Kai S Lindgren
Olli Vuolteenaho
Timo H Mäkikallio
P304
P356
10.1016/J.JACC.2003.09.048
P407
P577
2004-03-01T00:00:00Z